
|Articles|April 1, 2002
Mohs better suited to remove sebaceous carcinoma of eyelid
New York - With postexcision recurrence rates of 30 percent , Mohs surgery might be the better alternative in the treatment of sebaceous gland carcinoma, according to James M. Spencer, M.D.)
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














